Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
Open Access
- 23 July 2020
- journal article
- research article
- Published by Elsevier BV in EBioMedicine
- Vol. 58, 102911
- https://doi.org/10.1016/j.ebiom.2020.102911
Abstract
No abstract availableKeywords
Funding Information
- Agency of Science, Technology and Research (COVID19RF-001)
- National Medical Research Council
This publication has 43 references indexed in Scilit:
- Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteinsBiochemical and Biophysical Research Communications, 2014
- Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoproteinEMBO Molecular Medicine, 2012
- Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up StudyThe Journal of Immunology, 2011
- Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR MethodJournal of Clinical Microbiology, 2010
- Use of Recombinant Antigens To Detect Antibodies againstMycoplasma suis, with Correlation of Serological Results to Hematological FindingsClinical and Vaccine Immunology, 2007
- Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood productsTransfusion, 2006
- Antigenic Cross‐Reactivity between Severe Acute Respiratory Syndrome–Associated Coronavirus and Human Coronaviruses 229E and OC43The Journal of Infectious Diseases, 2005
- Human Coronaviruses: What Do They Cause?Antiviral Therapy, 2005
- Severe acute respiratory syndrome: review and lessons of the 2003 outbreakInternational Journal of Epidemiology, 2004
- Identification of an epitope of SARS-coronavirus nucleocapsid proteinCell Research, 2003